‘SIAMMS II’ was a prospective, single centre Phase I extension study in which participants in the SIAMMS study were offered repeat bone marrow harvest and infusion of autologous, unfractionated bone marrow as a day-case procedure.
[Multiple Sclerosis and Related Disorders]